WBC
West Branch Capital’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-50
| Closed | -$2.7K | – | 629 |
|
|
2024
Q2 | $2.7K | Hold |
50
| – | – | ﹤0.01% | 368 |
|
|
2024
Q1 | $3.41K | Hold |
50
| – | – | ﹤0.01% | 357 |
|
|
2023
Q4 | $3.13K | Hold |
50
| – | – | ﹤0.01% | 375 |
|
|
2023
Q3 | $2.27K | Hold |
50
| – | – | ﹤0.01% | 385 |
|
|
2023
Q2 | $2.81K | Hold |
50
| – | – | ﹤0.01% | 383 |
|
|
2023
Q1 | $2.26K | Hold |
50
| – | – | ﹤0.01% | 391 |
|
|
2022
Q4 | $2.03K | Hold |
50
| – | – | ﹤0.01% | 390 |
|
|
2022
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 383 |
|
|
2022
Q2 | $3K | Hold |
50
| – | – | ﹤0.01% | 365 |
|
|
2022
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 378 |
|
|
2021
Q4 | $4K | Hold |
50
| – | – | ﹤0.01% | 396 |
|
|
2021
Q3 | $6K | Hold |
50
| – | – | ﹤0.01% | 339 |
|
|
2021
Q2 | $8K | Buy |
+50
| New | +$8K | ﹤0.01% | 336 |
|